Le Cann P, Chabaud M, Leboulleux D, Mougin C, Mayelo V, Legrand M C, Calvet C, Afoutou J M, Coll-Seck A M, Coursaget P
Institut de Virologie, Faculté de Pharmacie, Tours, France.
J Med Virol. 1995 Apr;45(4):410-4. doi: 10.1002/jmv.1890450410.
Antibodies against eight synthetic peptides spanning different epitopes located on L1, L2, and E4 proteins of human papillomavirus (HPV) types 16, 6, and 11 were examined in sera from 73 women infected by HPV and from 139 healthy controls. Only three of these peptides were reactive. Two located on proteins L2 and E4 of HPV 16 seem type specific since antibodies to these peptides were detected, respectively, in 21% and 15% of the HPV 16 infected patients and in 2.5% and none of women infected by other HPVs. The third peptide located on the L1 protein of HPV 6 bears a common epitope since antibodies to this peptide were detected not only in 85% of women infected by HPV 6 or 11, but also in 82% of women infected by other HPVs, and in 74% and 71% of the control groups (10-12-year-old children and adults, respectively). In conclusion, none of the peptides investigated seems useful to develop ELISAs for serological diagnosis of HPV infection.
检测了针对人乳头瘤病毒(HPV)16、6和11型L1、L2和E4蛋白上不同表位的8种合成肽的抗体,这些抗体来自73名HPV感染女性的血清以及139名健康对照者的血清。这些肽中只有三种具有反应性。位于HPV 16型L2和E4蛋白上的两种肽似乎具有型特异性,因为分别在21%和15%的HPV 16感染患者中检测到了针对这些肽的抗体,而在其他HPV感染的女性中,检测到针对这些肽抗体的比例分别为2.5%和0。位于HPV 6型L1蛋白上的第三种肽具有一个共同表位,因为不仅在85%的HPV 6或11感染女性中检测到了针对该肽的抗体,在82%的其他HPV感染女性中也检测到了,在对照组(分别为10至12岁儿童和成年人)中检测到的比例分别为74%和71%。总之,所研究的肽似乎都无助于开发用于HPV感染血清学诊断的酶联免疫吸附测定(ELISA)。